Who really knows Anyone... or anything?!....A Measure of Protection!: 09.09.09

Problems reading this email? Click here to browse online.

Talk Medical (http://talk.news-medical.net). Post news from your organization or company, post events you are involved in or feel would be of interest to the wider community, blog to your heart's content on current health issues or simply just share any interesting health stories you may have.

Feature Blog Posts

The First Baby Step By The American Heart Association

On August 24, 2009, the American Heart Association published its new scientific statement that recommends Americans to reduce their intake of added sugar. This statement was written by its lead author, Rachel K. Johnson, Dean and Professor of Nutrition, The University of Vermont; Senior Nutrition Advisor, Eating Well Magazine, VT.

Read More

Latest News

Phase II trial of ANA598 commenced by Anadys Pharmaceuticals
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that dosing has begun in a Phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). The study will evaluate ANA598 over 12 weeks, taken in combination with pegylated interferon-alpha and ribavirin, in treatment naive HCV patients. ANA598 is an investigational, oral, non-nucleoside polymerase inhibitor.
http://www.news-medical.net/news/20090909/Phase-II-trial-of-ANA598-commenced-by-Anadys-Pharmaceuticals.aspx

Cepheid's Flu Panel test to provide 45-minute identification of Flu A infection
Cepheid (Nasdaq: CPHD) today announced the accelerated development of a Flu A (Influenza Virus) Panel test for use on the GeneXpert((R)) System. The test will be designed to provide 45-minute identification of Flu A infection, with specific presumptive identification of seasonal H1, seasonal H3, and H1N1 novel strain types.
http://www.news-medical.net/news/20090909/Cepheids-Flu-Panel-test-to-provide-45-minute-identification-of-Flu-A-infection.aspx

HCV treatment study reveals low relapse rate of Pegetron
Recently published in the New England Journal of Medicine, the largest prospective study of chronic hepatitis C virus (HCV) treatments Pegetron and Pegasys RBV (R) found both treatments equal in achieving sustained viral response. The study also found that Pegetron had a significantly lower relapse rate and is a safe and effective treatment option which has shown long term viral eradication.
http://www.news-medical.net/news/20090909/HCV-treatment-study-reveals-low-relapse-rate-of-Pegetron.aspx

WRAIR to test Kane Biotech's DispersinB biofilm technology against pathogens in combat trauma wounds
Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that the Company has entered into a Cooperative Research and Development Agreement for Material Transfer (CRADA-MT) with the Walter Reed Army Institute of Research (WRAIR) in Silver Springs, Maryland.
http://www.news-medical.net/news/20090909/WRAIR-to-test-Kane-Biotechs-DispersinB-biofilm-technology-against-pathogens-in-combat-trauma-wounds.aspx

MRSA awareness event to be held at Loyola University Chicago
MRSA Survivors Network, the Chicago-based nonprofit and official organization for World MRSA Day, along with fellow MRSA activists will lift the veil of secrecy surrounding MRSA. The history making inaugural kick-off event will be held at Loyola University Chicago on October 1st. The 2009 theme is "You Can Not Change What You Do Not Acknowledge."
http://www.news-medical.net/news/20090909/MRSA-awareness-event-to-be-held-at-Loyola-University-Chicago.aspx

International summit on the H1N1 influenza pandemic and critical business preparedness
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota is convening an international summit on the H1N1 influenza pandemic and critical business preparedness.
http://www.news-medical.net/news/20090909/International-summit-on-the-H1N1-influenza-pandemic-and-critical-business-preparedness.aspx

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella
Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health ("NIH") has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.
http://www.news-medical.net/news/20090909/Ceragenix-awarded-24287M-NIH-grant-to-develop-a-drug-for-treating-Clostrdium-difficile-and-Shigella.aspx

Physicians to educate Congress on the importance of reducing viral hepatitis
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
http://www.news-medical.net/news/20090909/Physicians-to-educate-Congress-on-the-importance-of-reducing-viral-hepatitis.aspx

International Institute of Biomedical Sciences and Technology established for a global research initiative
Upstate Medical University in Syracuse, New York, the Technion-Israel Institute of Technology in Haifa, Israel, and National Cheng Kung University in Tainan City, Taiwan, have announced the creation of the International Institute of Biomedical Sciences and Technology that will facilitate the collaboration of research across three continents and accelerate the development of novel bioengineering, diagnostic and biomedical products for the treatment and cure of disease, officials said today.
http://www.news-medical.net/news/20090909/International-Institute-of-Biomedical-Sciences-and-Technology-established-for-a-global-research-initiative.aspx

Maxim Health to launch its annual influenza vaccination program on October 1
It is the start of the flu season and with seasonal influenza responsible for more than 36,000 deaths per year, getting a flu vaccine is critical. Today, Maxim Health Systems announced on October 1 it will launch its annual influenza vaccination program and will provide flu shots nationwide through more than 44,000 clinics.
http://www.news-medical.net/news/20090909/Maxim-Health-to-launch-its-annual-influenza-vaccination-program-on-October-1.aspx

Consortium awarded $3.75M to set up an AIDS research center in Chicago
The National Institutes of Health (NIH) has awarded a consortium of Chicago-based institutions, led by Rush University Medical Center, a five-year, $3.75-million grant to establish a Developmental Center for AIDS Research, creating a comprehensive research infrastructure to spur basic science, clinical studies and translational research in the prevention, detection and treatment of HIV infection and AIDS.
http://www.news-medical.net/news/20090909/Consortium-awarded-24375M-to-set-up-an-AIDS-research-center-in-Chicago.aspx

Amarillo Biosciences is midway in Phase 2 clinical study of interferon against H1N1
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
http://www.news-medical.net/news/20090909/Amarillo-Biosciences-is-midway-in-Phase-2-clinical-study-of-interferon-against-H1N1.aspx

Sinovac's first lot of H1N1 vaccine released by China's NICPBP
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.
http://www.news-medical.net/news/20090909/Sinovacs-first-lot-of-H1N1-vaccine-released-by-Chinas-NICPBP.aspx

Rice researchers describe a new method to predict the efficacy of H1N1 vaccines
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.
http://www.news-medical.net/news/20090909/Rice-researchers-describe-a-new-method-to-predict-the-efficacy-of-H1N1-vaccines.aspx

NIH awards Vaxart $2.8M grant to develop an orally-delivered H5N1 Avian influenza vaccine
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has been awarded a $2.8 million phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (National Institutes of Health) to support development of its first product, an orally-delivered vaccine for H5N1 Avian influenza.
http://www.news-medical.net/news/20090909/NIH-awards-Vaxart-2428M-grant-to-develop-an-orally-delivered-H5N1-Avian-influenza-vaccine.aspx

Individuals with upper-GI symptoms visit general practitioners often
Patients with upper gastrointestinal (GI) complaints visit their general practitioner (GP) more often than patients with other conditions. Researchers writing in the open access journal BMC Family Practice found that people with dyspepsia, heartburn, epigastric discomfort and other upper-abdominal complaints had almost twice as many GP contacts, which were ultimately associated with problems in all organ systems.
http://www.news-medical.net/news/20090909/Individuals-with-upper-GI-symptoms-visit-general-practitioners-often.aspx

Inactivation of ClpX gene may help treat anthrax poisoning
Scientists from the University of California (San Diego) have identified a gene in B. anthracis that not only contributes to the severity of the anthrax disease but also makes it more difficult for a patient's immune system to fight the infection.
http://www.news-medical.net/news/20090908/Inactivation-of-ClpX-gene-may-help-treat-anthrax-poisoning.aspx

Major advance in understanding Friedreich's ataxia
University of Sydney researchers have made a significant advance in understanding the debilitating hereditary disease Friedreich's ataxia, offering hope that new forms of treatment will be developed.
http://www.news-medical.net/news/20090908/Major-advance-in-understanding-Friedreichs-ataxia.aspx

MyMedicalRecords PHR offers medical reimbursement for H1N1 affected susbcribers
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.
http://www.news-medical.net/news/20090908/MyMedicalRecords-PHR-offers-medical-reimbursement-for-H1N1-affected-susbcribers.aspx

CEO Cancer Gold Standard accreditation for Independence Blue Cross
Philadelphia-based Independence Blue Cross has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.
http://www.news-medical.net/news/20090908/CEO-Cancer-Gold-Standard-accreditation-for-Independence-Blue-Cross.aspx

Third human clinical trial of LigoCyte's norovirus vaccine started
LigoCyte Pharmaceuticals, Inc. announced today that it has initiated its third human clinical trial of its norovirus vaccine. The Phase I/II study will assess safety and immunogenicity associated with LigoCyte's investigational, nasally-delivered, dry powder vaccine in healthy adults. The study will also assess potential protection against clinical symptoms of norovirus infection by including a live virus challenge of subjects that have received either the vaccine or placebo.
http://www.news-medical.net/news/20090908/Third-human-clinical-trial-of-LigoCytes-norovirus-vaccine-started.aspx

Chronic pediatric cough linked to reflux and allergies
New research shows that chronic cough in children is most often caused by gastroesophageal reflux and allergies. Researchers from Tulane University in New Orleans, LA, evaluated 40 patients aged 5 to 12 years with chronic cough (> 8 weeks in duration) with no obvious cause. Each patient underwent extensive multispecialty testing. Results showed that reflux was the single most commonly associated factor of chronic cough by itself (27.5 percent), followed by allergy (22.5 percent).
http://www.news-medical.net/news/20090908/Chronic-pediatric-cough-linked-to-reflux-and-allergies.aspx

Prevalence of cortical gray matter atrophy may be overestimated in healthy aging brain
The belief that healthy older brains are substantially smaller than younger brains may stem from studies that did not screen out people whose undetected, slowly developing brain disease was killing off cells in key areas, according to new research. As a result, previous findings may have overestimated atrophy and underestimated normal size for the older brain.
http://www.news-medical.net/news/20090908/Prevalence-of-cortical-gray-matter-atrophy-may-be-overestimated-in-healthy-aging-brain.aspx

New probiotic provides protection against the fatal E. coli disease
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.
http://www.news-medical.net/news/20090908/New-probiotic-provides-protection-against-the-fatal-E-coli-disease.aspx

Microbe's multilayer defence mechanisms could treat fungal infections
Unravelling a microbe's multilayer defence mechanisms could lead to effective new treatments for potentially lethal fungal infections in cancer patients and others whose natural immunity is weakened.
http://www.news-medical.net/news/20090908/Microbes-multilayer-defence-mechanisms-could-treat-fungal-infections.aspx

Cognitive abilities decline more for people with Alzheimer's disease due to infections
Getting a cold, stomach bug or other infection may lead to increased memory loss in people with Alzheimer's disease, according to research published in the September 8, 2009, print issue of Neurology-, the medical journal of the American Academy of Neurology.
http://www.news-medical.net/news/20090908/Cognitive-abilities-decline-more-for-people-with-Alzheimers-disease-due-to-infections.aspx

Tool to aid health organizations tackle spread of pandemic diseases
OAG, the leading provider of global airline data and intelligence, has developed a prototype to assist health organizations and government agencies in preparing their strategies to combat the spread of pandemic diseases, including the H1N1 virus and other flu strains.
http://www.news-medical.net/news/20090907/Tool-to-aid-health-organizations-tackle-spread-of-pandemic-diseases.aspx

Study calls for compelling messages to induce washing of hands
"Many students say they routinely wash their hands," said Douglas Powell, an associate professor of food safety at Kansas State University. "But even in an outbreak situation, many students simply don't."
http://www.news-medical.net/news/20090905/Study-calls-for-compelling-messages-to-induce-washing-of-hands.aspx

Recent releases: PEPFAR in Zimbabwe; dengue in Thailand; blogs on improving U.S. foreign aid; examining allocations of health aid
The U.S. plans to support efforts to develop a sustainable health system in Zimbabwe and increase its capacity to treat people, Eric Goosby, U.S. global AIDS Coordinator for PEPFAR, said on Wednesday after a visit to the country with USAID and CDC officials, according to a press release from the U.S. Embassy in Harare, Zimbabwe. Goosby said he is "optimistic" that the Zimbabwe PEPFAR team's experience will be used "to develop a response that fits the existing health infrastructure, supports it and reinforces it in a way that creates a durable and lasting response" (9/2).
http://www.news-medical.net/news/20090905/Recent-releases-PEPFAR-in-Zimbabwe3b-dengue-in-Thailand3b-blogs-on-improving-US-foreign-aid3b-examining-allocations-of-health-aid.aspx

Sinovac to purchase H1N1 vaccine for the national stockpiling plan
Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling plan.
http://www.news-medical.net/news/20090905/Sinovac-to-purchase-H1N1-vaccine-for-the-national-stockpiling-plan.aspx

Nurses urge CDC to follow the recommendations for swine flu protection from the Institute of Medicine
The California Nurses Association/National Nurses Organizing Committee (CNA/NNOC) today applauds the Institute of Medicine for recommending strong patient safety protections for patients and caregivers to avoid airborne transmission during the ongoing H1N1/swine flu pandemic--and calls on the Centers for Disease Control to meet the same, stringent standards.
http://www.news-medical.net/news/20090905/Nurses-urge-CDC-to-follow-the-recommendations-for-swine-flu-protection-from-the-Institute-of-Medicine.aspx

Bloodstream infections can be avoided with a daily scrub solution bath
Giving critically ill hospital patients a daily bath with a mild, soapy solution of the same antibacterial agent used by surgeons to "scrub in" before an operation can dramatically cut down, by as much as 73 percent, the number of patients who develop potentially deadly bloodstream infections, according to a new study by patient safety experts at The Johns Hopkins Hospital and five other institutions.
http://www.news-medical.net/news/20090905/Bloodstream-infections-can-be-avoided-with-a-daily-scrub-solution-bath.aspx

Researchers discover the causes for the severity of RSV illness
Approximately one-half of all infants are infected with the respiratory syncytial virus (RSV) during the first year of life, and almost all children have been infected at least once by the time they reach their second birthday. Researchers at West Virginia University have discovered what makes RSV such a severe and persistent illness.
http://www.news-medical.net/news/20090904/Researchers-discover-the-causes-for-the-severity-of-RSV-illness.aspx

New report on the global market for liver disease treatments from Reportlinker
This Report:Provides an overview of the global market for liver disease treatments, with market forecasts through 2014
http://www.news-medical.net/news/20090904/New-report-on-the-global-market-for-liver-disease-treatments-from-Reportlinker.aspx

Touch of MIDAS to prepare the world for contagious outbreaks
To help the nation-and the world-understand and prepare for contagious outbreaks, the National Institutes of Health's Models of Infectious Disease Agent Study (MIDAS) adds new research expertise to increase its capacity to simulate disease spread, evaluate different intervention strategies and help inform public health officials and policymakers.
http://www.news-medical.net/news/20090904/Touch-of-MIDAS-to-prepare-the-world-for-contagious-outbreaks.aspx

Clinical trial of Novartis MF59 swine-flu vaccine elicits a strong immune response
Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.
http://www.news-medical.net/news/20090904/Clinical-trial-of-Novartis-MF59-swine-flu-vaccine-elicits-a-strong-immune-response.aspx

New center to study mathematical modeling of drug resistance and internention to be established at HSPH
A new center that will focus on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health (HSPH).
http://www.news-medical.net/news/20090904/New-center-to-study-mathematical-modeling-of-drug-resistance-and-internention-to-be-established-at-HSPH.aspx

Adding screens to homes can cut malaria risk, study says
A study conducted in the Republic of The Gambia found that adding screens to the windows and doors of houses can help reduce the number of malaria-carrying mosquitoes inside and prevent anaemia in children, CBCnews.ca reports (9/2).
http://www.news-medical.net/news/20090904/Adding-screens-to-homes-can-cut-malaria-risk-study-says.aspx

Two new antibodies for targeting HIV virus discovered
Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram Biosciences have discovered two powerful new antibodies to HIV that reveal what may be an Achilles heel on the virus. They published their work in Science this week.
http://www.news-medical.net/news/20090903/Two-new-antibodies-for-targeting-HIV-virus-discovered.aspx

Seasonal flu vaccinations increases by 237% this season compared to the same four weeks during last season
According to SDI, a leading healthcare market insight and analytics firm that consolidates electronic healthcare claims data, there have been over 477,000 seasonal flu vaccinations already administered through Aug. 29 — the fourth week of this year's flu season. That is an increase of 237% compared to the same four weeks during last season.
http://www.news-medical.net/news/20090903/Seasonal-flu-vaccinations-increases-by-23725-this-season-compared-to-the-same-four-weeks-during-last-season.aspx

Outbreaks Near Me iPhone application tracks and reports outbreaks of infectious diseases in real-time
A new iPhone application, created by researchers at Children's Hospital Boston in collaboration with the MIT Media Lab, enables users to track and report outbreaks of infectious diseases, such as H1N1 (swine flu), on the ground in real time.
http://www.news-medical.net/news/20090903/Outbreaks-Near-Me-iPhone-application-tracks-and-reports-outbreaks-of-infectious-diseases-in-real-time.aspx

Recurrence of Clostridium difficile infection is a growing area of concern in hospitals
Arlington Medical Resources (AMR) and Decision Resources find that relapse or recurrence of infections is the most challenging aspect of treating Clostridium difficile infections in the hospital setting.
http://www.news-medical.net/news/20090903/Recurrence-of-Clostridium-difficile-infection-is-a-growing-area-of-concern-in-hospitals.aspx

First swine-flu vaccine trials reveal strong immune response
Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.
http://www.news-medical.net/news/20090903/First-swine-flu-vaccine-trials-reveal-strong-immune-response.aspx

Sinovac Biotech signs marketing agreement with Boryung Pharmaceutical Company
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has signed an agreement with Boryung Pharmaceutical Company Limited, a Korean manufacturer of pharmaceuticals, to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac's H1N1 vaccine.
http://www.news-medical.net/news/20090903/Sinovac-Biotech-signs-marketing-agreement-with-Boryung-Pharmaceutical-Company.aspx

Gene-Eden antiviral supplement may offer protection against swine flu
Everyone is looking for ways to protect themselves against the swine flu virus. Let me tell you about my personal encounter with the virus. About three months ago, I read an article on Dr. Hanan Polansky's book, where he describes his discovery of the relationship between chronic viruses and chronic disease. After I read the article, I started taking Gene-Eden, a broad range antiviral supplement, to reduce the number of chronic viruses in my body.
http://www.news-medical.net/news/20090903/Gene-Eden-antiviral-supplement-may-offer-protection-against-swine-flu.aspx

Healthcare-acquired infection costs $1 billion per annum
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
http://www.news-medical.net/news/20090903/Healthcare-acquired-infection-costs-241-billion-per-annum.aspx

Preliminary lab results of SHBAN hand sanitizer solution announced
BioTech Medics, Inc. (PINKSHEETS: BMCS) announces that it has received preliminary independent clinical testing of its patented SHBAN™ Hand Sanitizer Solution to demonstrate it kills the H1N1 (Swine) Influenza A virus.
http://www.news-medical.net/news/20090903/Preliminary-lab-results-of-SHBAN-hand-sanitizer-solution-announced.aspx

New York Times examines efforts to stop spread of dengue in Asia
"While emerging diseases like influenza A(H1N1), also known as swine flu, continue to dominate the headlines, experts say dengue is not only thriving in many endemic areas, it is also spreading to countries previously unaffected by the disease," New York Times writes.
http://www.news-medical.net/news/20090903/New-York-Times-examines-efforts-to-stop-spread-of-dengue-in-Asia.aspx

Increase in Rifampicin dosage shortens tuberculosis treatment duration
According to Dutch researcher Hanneke Later-Nijland, it may be possible to shorten the duration of treatment for tuberculosis. Due to the long duration of treatment, not every patient sees it through. Partly because of this, tuberculosis is one of the most lethal diseases in developing countries.
http://www.news-medical.net/news/20090903/Increase-in-Rifampicin-dosage-shortens-tuberculosis-treatment-duration.aspx

Molecular pathology laboratories gear up for swift swine flu detection
Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments today at the Clinical Laboratory Improvement Advisory Committee meeting.
http://www.news-medical.net/news/20090903/Molecular-pathology-laboratories-gear-up-for-swift-swine-flu-detection.aspx

Obama urges Americans to take precautions to protect themselves from H1N1
After a day of meetings with senior White House officials to discuss the U.S. preparations for H1N1 (swine) flu Tuesday, President Obama urged Americans to take the proper precautions to protect themselves from infection, the Associated Press/Boston Herald reports (9/1).
http://www.news-medical.net/news/20090903/Obama-urges-Americans-to-take-precautions-to-protect-themselves-from-H1N1.aspx

The 2009 H1N1 influenza virus causes more severe disease than human seasonal influenza viruses
Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Tests in animals showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains, and the new virus caused more severe disease. In line with previous findings by other research groups, the University of Maryland researchers also observed that the novel H1N1 virus was transmitted more easily from infected to uninfected ferrets than either of the two seasonal influenza viruses.
http://www.news-medical.net/news/20090902/The-2009-H1N1-influenza-virus-causes-more-severe-disease-than-human-seasonal-influenza-viruses.aspx

Linkwell concerned with misunderstanding of prevention and control measures of H1N1
Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.
http://www.news-medical.net/news/20090902/Linkwell-concerned-with-misunderstanding-of-prevention-and-control-measures-of-H1N1.aspx

Government, medical and community experts to discuss about prevention and detection of viral hepatitis
To address this public health challenge, government, medical and community experts will meet September 10-11 in Washington, D.C. to plan an improved national response to viral hepatitis. The conference "The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C" will feature keynote addresses, panel discussions and scientific poster sessions focused on enhancing the prevention and detection of viral hepatitis and improving care for people who are already living with the disease.
http://www.news-medical.net/news/20090902/Government-medical-and-community-experts-to-discuss-about-prevention-and-detection-of-viral-hepatitis.aspx

NPMA warns homeowners of mosquito infestations during the fall months
As summer begins to fade, the National Pest Management Association (NPMA) reminds homeowners of the ongoing caution necessary when dealing with increased mosquito populations across the United States. Although the itchy welts of mosquitoes are associated with summer, these pests flourish well into the fall months and can transmit a multitude of diseases, notably West Nile virus (WNV).
http://www.news-medical.net/news/20090902/NPMA-warns-homeowners-of-mosquito-infestations-during-the-fall-months.aspx

Pathogenic microbes can suppress immune system in newborns
Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to researchers at the University of California, San Diego School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences.
http://www.news-medical.net/news/20090902/Pathogenic-microbes-can-suppress-immune-system-in-newborns.aspx

Alpha Pro Tech to triple N-95 respirator mask production
Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that it will be tripling the average output of N-95 respirator masks that it has been producing since May, which will help accommodate Alpha Pro Tech's current backlog and increase availability for the upcoming flu season/swine flu season.
http://www.news-medical.net/news/20090902/Alpha-Pro-Tech-to-triple-N-95-respirator-mask-production.aspx

Single-dose H1N1 vaccine wins approval in China
The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China's State Food and Drug Administration, the Associated Press/Forbes reports. The company expects to obtain a production license later this week. According to the company, clinical trials of the H1N1 vaccine showed a single shot produced an immune response capable of protecting against H1N1 (8/31).
http://www.news-medical.net/news/20090902/Single-dose-H1N1-vaccine-wins-approval-in-China.aspx

Condoms reduce risk of herpes simplex virus 2
Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
http://www.news-medical.net/news/20090902/Condoms-reduce-risk-of-herpes-simplex-virus-2.aspx

TeleForum to discuss H1N1 precautions on campus
In response to the Centers for Disease Control and Prevention's expectation of increased cases of H1N1 flu as students return to school this fall, Colorado-based Broadnet is offering a unique package of its virtual town hall service, TeleForum, to colleges and universities in an effort to aid communication with parents, communities and students.
http://www.news-medical.net/news/20090902/TeleForum-to-discuss-H1N1-precautions-on-campus.aspx

Gates Foundation appoints new HIV program head
The Bill & Melinda Gates Foundation recently announced that Stefano Bertozzi will head up its HIV programs starting August 31, the Puget Sound Business Journal reports (8/27).
http://www.news-medical.net/news/20090901/Gates-Foundation-appoints-new-HIV-program-head.aspx

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season
Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.
http://www.news-medical.net/news/20090831/Rite-Aid-pharmacies-to-offer-regular-seasonal-flu-shots-throughout-the-flu-season.aspx

Fernando Pisani and 24 hockey players helped raise funds and awareness about Crohn's disease and ulcerative colitis
The spirit of giving back was as strong as ever this weekend at the first ever Score for Colitis & Crohn's event, which raised $20,000 for four gastrointestinal and digestive disease patient organizations from across the country. The Score for Colitis & Crohn's initiative, which took place at the West Edmonton Mall's Ice Palace on Saturday, August 29th, featured Fernando Pisani of the Edmonton Oilers and 24 aspiring young hockey enthusiasts who were all on hand to help raise funds and awareness about Crohn's disease and ulcerative colitis, the latter of which Pisani was diagnosed with in 2007.
http://www.news-medical.net/news/20090831/Fernando-Pisani-and-24-hockey-players-helped-raise-funds-and-awareness-about-Crohns-disease-and-ulcerative-colitis.aspx

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.
http://www.news-medical.net/news/20090831/FDA-approves-the-usage-of-Valcyte-for-preventing-CMV-disease-in-pediatric-patients.aspx

Researchers develop an index scale to help physicians predict a patient's risk of dying from COPD
Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.
http://www.news-medical.net/news/20090829/Researchers-develop-an-index-scale-to-help-physicians-predict-a-patients-risk-of-dying-from-COPD.aspx

Antibiotic functioning as an off switch being developed for gene therapy of Parkinson's disease
A common antibiotic can function as an "off switch" for a gene therapy being developed for Parkinson's disease, according to University of Florida researchers writing online in advance of September's Molecular Therapy.
http://www.news-medical.net/news/20090829/Antibiotic-functioning-as-an-off-switch-being-developed-for-gene-therapy-of-Parkinsons-disease.aspx

Scientists study the impact of nerve growth factors for treating Parkinson's disease
Scientists in the Academy of Finland's Neuroscience Research Programme have reported promising new results with potential implications for the treatment of Parkinson's disease. They have been studying the impacts of nerve growth factors in the treatment of PD, and their latest results show that a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells.
http://www.news-medical.net/news/20090828/Scientists-study-the-impact-of-nerve-growth-factors-for-treating-Parkinsons-disease.aspx

HIV subtype D infected patients more likely to develop dementia
Patients infected with a particular subtype of HIV, the virus that causes AIDS, are more likely to develop dementia than patients with other subtypes, a study led by Johns Hopkins researchers shows. The finding, reported in the September Clinical Infectious Diseases, is the first to demonstrate that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.
http://www.news-medical.net/news/20090828/HIV-subtype-D-infected-patients-more-likely-to-develop-dementia.aspx

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau
Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. The agreement will be executed after the public notice period.
http://www.news-medical.net/news/20090828/Sinovac-to-supply-its-Anflu-seasonal-flu-vaccine-to-the-Beijing-Public-Health-Bureau.aspx

NAT gains importance as traditional testing methods become inadequate
An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).
http://www.news-medical.net/news/20090828/NAT-gains-importance-as-traditional-testing-methods-become-inadequate.aspx

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart
QRS duration (QRSd) is one of several measures of heart function recorded during a routine electrocardiogram (ECG). It is a composite of waves showing the length of time it takes for an electrical signal to get all the way through the pumping chambers of the heart. Prolonged QRSd is a sign of an abnormal electrical system of the heart and is often found when the heart isn't pumping efficiently.
http://www.news-medical.net/news/20090828/NYPWeill-Cornell-research-reveals-that-prolonged-QRS-duration-indicates-abnormal-pumping-of-the-heart.aspx

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
http://www.news-medical.net/news/20090828/WTN-Services-and-Winetasting-Network-to-be-lead-corporate-sponsors-of-the-Annual-AIDS-Walk-Napa-Valley.aspx

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints
Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.
http://www.news-medical.net/news/20090828/Urine-LAM-ELISAs-sensitivity-of-50725-in-identifying-TB-disappoints.aspx

TRAF6 protein can activate a cell signalling molecule associated with cancer
The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with cancer growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 28 edition of Science.
http://www.news-medical.net/news/20090828/TRAF6-protein-can-activate-a-cell-signalling-molecule-associated-with-cancer.aspx

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans
According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S. conducted a multicenter retrospective-prospective study of the waitlist status and outcomes of liver transplant patients with HBV infection.
http://www.news-medical.net/news/20090828/Caucasians-have-a-higher-rate-of-HBV-recurrence-compared-to-Asian-Americans-and-African-Americans.aspx

Elorac offers Zithranol-RR for treating plaque psoriasis
Now patients with mild to moderate plaque psoriasis have a new topical treatment option available by prescription. Zithranol™-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%), is an innovative topical therapy for plaque psoriasis according to Elorac, Inc., a privately held emerging dermatology company. Zithranol™-RR provides an advanced delivery system for anthralin achieving long remission times with no long-term side effects in a steroid-free, silky cream.
http://www.news-medical.net/news/20090828/Elorac-offers-Zithranol-RR-for-treating-plaque-psoriasis.aspx

Infectious Disease Research Institute commences clinical trial of its leishmaniasis vaccine in Sudan
IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children.
http://www.news-medical.net/news/20090828/Infectious-Disease-Research-Institute-commences-clinical-trial-of-its-leishmaniasis-vaccine-in-Sudan.aspx

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
http://www.news-medical.net/news/20090828/NIMH-grants-Xhale-2417-million-to-develop-the-SMART-medication-adherence-system-for-HIVAIDS-therapies.aspx

Maxim Health Systems' website provides detailed information about flu vaccination
Maxim's dedicated flu Web site provides detailed information about the flu vaccination and allows consumers to locate seasonal flu clinics in their area by searching by zip code. In addition, Maxim is preparing to launch several new online resources for consumers to protect themselves and their families this flu season.
http://www.news-medical.net/news/20090828/Maxim-Health-Systems-website-provides-detailed-information-about-flu-vaccination.aspx

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy
Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.
http://www.news-medical.net/news/20090828/Chk1-and-Fbx6-play-an-important-role-for-the-regulation-of-response-to-chemotherapy.aspx

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends
UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).
http://www.news-medical.net/news/20090828/Also-in-global-health-news-NTD-study3b-false-cholera-cases-in-Zimbabwe3b-contaminated-water-in-Kenya3b-doctors-strike-ends.aspx

Brazil emerges as country with highest number of H1N1-related deaths
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, "making it the country with the highest number of fatalities in the world from the disease," according to the country's health ministry, Agence France-Presse reports. "Brazil's health ministry said in a statement the government was freeing up one billion dollars to buy 73 million doses of a new vaccine being developed against swine flu, as well as Tamiflu stocks, hospital equipment and diagnostic gear," the news service writes (8/26).
http://www.news-medical.net/news/20090828/Brazil-emerges-as-country-with-highest-number-of-H1N1-related-deaths.aspx

H1N1 virus detected in turkeys
The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today.
http://www.news-medical.net/news/20090827/H1N1-virus-detected-in-turkeys.aspx

Movember to present at the LIVESTRONG Global Cancer Summit
Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.
http://www.news-medical.net/news/20090827/Movember-to-present-at-the-LIVESTRONG-Global-Cancer-Summit.aspx

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects
EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.
http://www.news-medical.net/news/20090827/EDCTP-welcomes-proposals-for-tuberculosis-vaccines-and-HIVAIDS-treatment-projects.aspx

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine
Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.
http://www.news-medical.net/news/20090827/BMSN-and-ENTB-collaborate-with-Therinjectto-to-develop-a-new-immuno-therapeutic-cancer-vaccine.aspx

Aid agencies seek to access displaced Yemenis at 'high risk' of disease outbreaks
Aid agencies on Tuesday "appealed for better access" to "tens of thousands" of people in Yemen who have been displaced by violence and are facing "a high risk of outbreaks of malaria and diarrhoeal diseases among the already malnourished population," Reuters reports.
http://www.news-medical.net/news/20090827/Aid-agencies-seek-to-access-displaced-Yemenis-at-high-risk-of-disease-outbreaks.aspx

HHS webcast to discuss how pregnant women and new mothers can prepare for the H1N1 flu
The U.S. Department of Health and Human Services (HHS) will host a Webcast to discuss how pregnant women and new mothers can prepare for the H1N1 flu on Thursday, August 27th.
http://www.news-medical.net/news/20090827/HHS-webcast-to-discuss-how-pregnant-women-and-new-mothers-can-prepare-for-the-H1N1-flu.aspx

Relationship between the CD14 variation and the formation of portal lymphoid aggregates discovered
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others. Age, sex, alcohol consumption and liver sensitivity to gut-derived bacterial endotoxins, were the early factors defined to enhance the risk of fibrosis progression.
http://www.news-medical.net/news/20090827/Relationship-between-the-CD14-variation-and-the-formation-of-portal-lymphoid-aggregates-discovered.aspx

US Department of Health funds a project to enhance the quality of care to women of color suffering from HIV/AIDS
Dr. S. Vincent Grasso, a member of the Stevens Healthcare Information Technology Management Advisory Board and Seminar Leader for the Stevens Healthcare Educational Partnership (SHEP), will act as technical lead, solution provider and systems integrator within a nation-wide initiative to enhance the quality of care to women of color suffering from HIV/AIDS. The US Department of Health and Human Services is the funding agency for the project, which will be implemented in urban centers across America.
http://www.news-medical.net/news/20090827/US-Department-of-Health-funds-a-project-to-enhance-the-quality-of-care-to-women-of-color-suffering-from-HIVAIDS.aspx

Invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in biliary tract cancer
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
http://www.news-medical.net/news/20090826/Invasive-front-dominant-expression-of-LNceb32-and-LNceb23-and-active-MMP7-play-a-key-role-in-biliary-tract-cancer.aspx

Researchers reveal that genes contributing to drug resistance in NSCLC disease could be predicted
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.
http://www.news-medical.net/news/20090826/Researchers-reveal-that-genes-contributing-to-drug-resistance-in-NSCLC-disease-could-be-predicted.aspx

Mutations associated with prion diseases are sufficient to cause transmissible neurodegenerative disease
For the first time, Whitehead Institute researchers have shown definitively that mutations associated with prion diseases are sufficient to cause a transmissible neurodegenerative disease.
http://www.news-medical.net/news/20090826/Mutations-associated-with-prion-diseases-are-sufficient-to-cause-transmissible-neurodegenerative-disease.aspx

Viral polymerase may provide a new therapeutic target for host-adapted avian influenza
Current research suggests that viral polymerase may provide a new therapeutic target for host-adapted avian influenza. The related report by Gabriel et al, "Spread of Infection and Lymphocyte Depletion in Mice Depends on Polymerase of Influenza Virus" appears in the September 2009 issue of the American Journal of Pathology.
http://www.news-medical.net/news/20090826/Viral-polymerase-may-provide-a-new-therapeutic-target-for-host-adapted-avian-influenza.aspx

Asia will experience H1N1 vaccine shortage, WHO says
A spokesperson for the WHO said on Tuesday that Asia will not have enough H1N1 vaccines for swine flu when cold weather hits, Reuters reports.
http://www.news-medical.net/news/20090826/Asia-will-experience-H1N1-vaccine-shortage-WHO-says.aspx

Anti-glycan antibody positivity observed in celiac disease
Anti-microbial antibody formation has been reported in celiac disease. Relatively high positivity rates were observed for the conventional antibodies, for example, ASCA, anti-OmpW, and anti-I2, and they were known to decrease after a successful gluten free-diet. The importance of newly discovered inflammatory bowel disease-associated antibodies (including anti-glycan antibodies and anti-OMP) in celiac disease is not sure.
http://www.news-medical.net/news/20090826/Anti-glycan-antibody-positivity-observed-in-celiac-disease.aspx

The American Brain Tumor Association to pursue increased funding of brain tumor research in Senator Kennedy's memory
The following is a statement by Elizabeth Wilson, Executive Director, American Brain Tumor Association on the death of U.S. Senator Edward M. Kennedy: "Senator Kennedy's brain tumor diagnosis just over a year ago brought international attention to this dreadful and devastating disease. He will be remembered as a tireless health care advocate who displayed courage and strength in his final battle against an unrelenting illness.
http://www.news-medical.net/news/20090826/The-American-Brain-Tumor-Association-to-pursue-increased-funding-of-brain-tumor-research-in-Senator-Kennedys-memory.aspx

Patient health and safety survey reveals that healthcare facilities are not ready to combat swine flu pandemic
A patient health and safety survey of 190 American hospitals from coast to coast compiled by registered nurses in eight different states finds that a disturbing number of our nation's healthcare facilities are not prepared for the coming H1N1/swine flu pandemic, according to results released today by the California Nurses Association/National Nurses Organizing Committee.
http://www.news-medical.net/news/20090826/Patient-health-and-safety-survey-reveals-that-healthcare-facilities-are-not-ready-to-combat-swine-flu-pandemic.aspx

Los Angeles County does not care about young people who appear in porn says President of AIDS Healthcare Foundation
In response to AIDS Healthcare Foundation's (AHF) legal petition for a writ of mandate to compel Los Angeles County's Department of Public Health to fight the spread of sexually transmitted diseases in the porn industry, County attorneys have filed an eye-popping demurrer that shows the County's complete disregard for young people working as performers in the $13 billion porn industry as well as revealing a strikingly blasé attitude by County officials toward potential County-wide general public health ramifications of serious infectious diseases, including transmission of several debilitating sexually transmitted diseases, including HIV.
http://www.news-medical.net/news/20090826/Los-Angeles-County-does-not-care-about-young-people-who-appear-in-porn-says-President-of-AIDS-Healthcare-Foundation.aspx

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues
NexBio, Inc. announced today the publication "DAS181 Inhibits H5N1 Influenza Lung Virus Infection of Human Lung Tissues" in the September, 2009 issue of the journal Antimicrobial Agents and Chemotherapy (AAC).
http://www.news-medical.net/news/20090826/DAS181-inhibits-H5N1-Influenza-lung-virus-infection-of-human-lung-tissues.aspx

To Unsubscribe simply click this link and check the unsubscribe box without entering any further information. To Modify your Email Address click here to make your changes.

News-Medical.Net (AZoM.com Pty.Ltd.)
Suite 24, MVB
90 Mona Vale Road
Mona Vale
Sydney
NSW, 2103
Australia

Tel: Direct +61 2 9999 0070
e-mail: info@news-medical.net